DAB2IP inhibits p53 ubiquitin-mediated degradation by competitively binding to GRP75 and suppresses tumor malignancy in colon cancer
Shen, J.; Feng, S.; Deng, J.; Huang, Q.; Zhao, D.; Jia, W.; Li, X.; Tao, D.; Gong, J.; Xie, D.; Liu, L.
Show abstract
Increasing evidence has shown that DAB2IP acts as a tumor suppressor and plays an inhibition role in many tumors. However, the underlying mechanism is still uncertain. Our study shows that DAB2IP is positively associated with a better prognosis in colon cancer patients with wild-type TP53 expression. In vitro assay shows that DAB2IP elicits potent tumor-suppressive effects on inhibiting cell invasiveness, colony formation and promoting cell apoptosis in wild-type TP53 colon cancer cell lines. Subsequently, DAB2IP is demonstrated to up-regulate the stability of wild-type TP53 by inhibiting its degradation in a ubiquitin-proteasome-dependent manner. Using mass spectrometry profiling, we unveil that DAB2IP and p53 could both interact with the ubiquitin ligase-related protein, GRP75. Mechanistically, DAB2IP could competitively bind with GRP75, thus reducing GRP75-mediated p53 ubiquitination and degradation. Finally, animal experiments also reveal that DAB2IP inhibits the tumor progression in vivo. In conclusion, our study presents a novel function of DAB2IP in GRP75-driven wild-type p53 degradation, which provides a new insight in DAB2IP-induced tumor suppression and provides a novel molecular aspect of the p53 pathway.
Matching journals
The top 14 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- ORMDL1 is upregulated and associated with favorable outcome in colorectal cancer 97%
- TMEM180 contributes to colorectal cancer proliferation through intracellular metabolic pathways 93%
- PMAIP1-Mediated Glucose Metabolism and its Impact on the Tumor Microenvironment in Breast Cancer: Integration of Multi-Omics Analysis and Experimental Validation 93%
Similar papers in this journal
- STAMBPL1 activates the GRHL3/HIF1A/VEGFA axis through interaction with FOXO1 to promote angiogenesis in triple-negative breast cancer 95%
- RGS10 deficiency facilitates distant metastasis by inducing epithelial-mesenchymal transition in breast cancer 95%
- Phosphodiesterase 1A physically interacts with YTHDF2 and reinforces the progression of non-small cell lung cancer 95%
Similar papers in this journal
- Identification of cuproptosis and ferroptosis-related subtypes and development of a prognostic signature in colon cancer 96%
- LINC01117 inhibits invasion and migration of lung adenocarcinoma through influencing EMT process 96%
- Research of the mechanism on miRNA193 in exosomes promotes cisplatin resistance in esophageal cancer cells 95%
Similar papers in this journal
- Tumors cells with mismatch repair deficiency induce hyperactivation of Pyroptosis resistant to cell membrane damage but are more sensitive to Co-treatment of IFN-γ and TNF-α to PANoptosis 96%
- Effect of OASL on OXA-induced immunogenic cell death in gastric cancer via cGAS-STING pathway 95%
- The oncogenic E3 ligase TRIP12 suppresses epithelial-mesenchymal transition (EMT) and metastasis-related processes through ZEB1/2 93%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.